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Rapid uropathogen identification 
using surface enhanced Raman 
spectroscopy active filters
Simon D. Dryden1*, Salzitsa Anastasova2, Giovanni Satta3, Alex J. Thompson1,2,4,5*, 
Daniel R. Leff1,2,5 & Ara Darzi1,2,5
Urinary tract infection is one of the most common bacterial infections leading to increased morbidity, 
mortality and societal costs. Current diagnostics exacerbate this problem due to an inability to provide 
timely pathogen identification. Surface enhanced Raman spectroscopy (SERS) has the potential to 
overcome these issues by providing immediate bacterial classification. To date, achieving accurate 
classification has required technically complicated processes to capture pathogens, which has 
precluded the integration of SERS into rapid diagnostics. This work demonstrates that gold-coated 
membrane filters capture and aggregate bacteria, separating them from urine, while also providing 
Raman signal enhancement. An optimal gold coating thickness of 50 nm was demonstrated, and the 
diagnostic performance of the SERS-active filters was assessed using phantom urine infection samples 
at clinically relevant concentrations  (105 CFU/ml). Infected and uninfected (control) samples were 
identified with an accuracy of 91.1%. Amongst infected samples only, classification of three bacteria 
(Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae) was achieved at a rate of 91.6%.
Abbreviations
AMR  Antimicrobial resistance
M,C&S  Microscopy culture and sensitivity
PBS  Phosphate buffered solution
PCA  Principal component analysis
PC-LDA  Principal component–linear discriminant analysis
PVD  Physical vapour deposition
PVDF  Polyvinylidene Fluoride
SERS  Surface enhanced Raman spectroscopy
150 million people worldwide are diagnosed with one or more urinary tract infections (UTIs) each year, making 
this one of the most commonly acquired infections in  humans1–3. The ubiquity of UTIs rapidly translates into a 
significant health burden, with UTIs accounting for 10.5 million healthcare visits in the United States alone, of 
which a fifth are to emergency  departments4. UTIs account for $6 billion in worldwide direct healthcare costs 
 annually2. Furthermore, UTIs predispose patients to severe and life-threatening conditions, with the risk of 
pyelonephritis increased by a factor of 4.45. Similarly, one tenth of sepsis cases arise from a urinary source, a 
condition with an 8% mortality  rate6.
Current diagnostics for UTIs have significant limitations, which further exacerbates the burden caused by 
UTIs. Screening tests such as urinalysis, while rapid, are inaccurate with sensitivities and specificities of 80%7,8. 
This leads to delayed recognition in 20% of infected cases and unnecessary treatment in 20% of uninfected 
 cases8–11. Furthermore, the inability of screening tests to identify the causative bacteria necessitates treatment 
with broad spectrum antimicrobials, known to have worse adverse effect profiles, mediated by host microbiome 
disruption, as well as a propensity to induce antimicrobial resistance (AMR)12–14. Gold standard testing through 
microscopy, culture and sensitivity (M,C&S), on the other hand, provides accurate microbial classification but 
incurs significant delays with as long as 72 h from specimen retrieval to  results7,15.
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Raman spectroscopy uses the inelastic scattering of light to provide whole organism fingerprinting and 
has demonstrable accuracy for bacterial sub-classification16–18. However, weak bacterial Raman signals have 
necessitated technical and time-consuming processing  steps19–22. Additionally, the majority of published works 
on uropathogen identification involve Raman microscopes as opposed to Raman spectroscopy. Whilst Raman 
microscopy offers the advantage of fine control of a narrow spot size as low as 1 μm, therein allowing for the 
collection of spectra from individual cells without competing signal from the background  medium23, their high 
cost and large physical footprint will not allow their use in the clinical setting. Moreover, identification of patho-
gens on which to focus the laser is time-consuming and requires technical expertise. In one study, 10–30% of 
collected spectra needed to be sorted out due to suboptimal  focusing24. Finally, as the user is required to focus 
the system onto the pathogen, Raman microscopes cannot distinguish infected from uninfected samples but 
are rather limited to classifying pathogens in samples already known to be infected. Work performed by Yang 
et al. has demonstrated Raman spectroscopy can accurately identify uropathogens after a multistep process of 
urine separation through centrifuge and washing followed by bacteriologic capture using electrostatic  forces22.
Surface enhanced Raman spectroscopy (SERS) provides Raman signal enhancement through the surface 
plasmon resonance effect afforded by the close application of metal nanostructures to the  microbes25,26. The SERS 
effect is strongly distance dependent, and as such a key challenge is to ensure close and consistent application of 
the microbes to the SERS-active  surface25. Membrane filtration is a microbiologic technique used to concentrate 
bacteria. A number of approaches have been used to combine membrane filtration with SERS for detection and 
identification of  bacteria27–30. However, the fabrication procedures used are typically complex, often involving 
separate preparation of metallic nanoparticles for SERS that are applied to the captured bacteria after filtration. 
Furthermore, where SERS-active surfaces have been directly fabricated on  filters31, the coating thicknesses have 
not been adequately optimized and the diagnostic potential has not been validated.
In this article, we report the application of a gold coating to polyvinylidene fluoride (PVDF) membranes 
using physical vapour deposition (PVD) to create SERS-active filters. This user-friendly, single-step process 
allows the coated membrane filters to perform three functions: capturing bacteria, separating them from the 
background medium (urine), and providing Raman signal enhancement. We optimized the thickness of the 
gold coating to achieve maximum SERS signal intensities while retaining the filtration capabilities. Then, by 
applying the filters in conjunction with vacuum filtration, we demonstrated the capability for detection and 
identification of bacteria in urine with high sensitivity and specificity using a commercially available handheld 
Raman spectrometer. Importantly, this was achieved without any pre-processing of the urine samples beyond 
vacuum filtration through the SERS-active membranes, demonstrating the potential of this approach for future 
use as a point-of-care diagnostic.
Results
SERS-active filters—optimization of gold coating thickness. The mean spectra of Rhodamine 6G 
on filters with varying gold coating thicknesses are plotted in Fig. 1a. The mean intensities of the four most 
prominent spectral peaks are presented in Table 1 and depicted in Fig. 1b. PVDF filters with a 50 nm gold coat-
ing applied through sputtered PVD provided the optimal signal enhancement for Rhodamine 6G, with clearly 
Figure 1.  Effect of gold coating thickness on Rhodamine 6G Raman spectra. (a) Mean Raman Spectra of 
Rhodamine 6G on PVDF filters with differing gold coating thicknesses. (b) Mean intensity with standard 
deviation (error bar) of the four most prominent peaks in the Rhodamine 6G spectra (1188, 1311, 1360 
and 1511  cm−1) for differing gold coating thicknesses. Thickness greater than 2.5 nm provided significant 
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defined peaks significantly above those observed in spectra acquired from unsputtered filters and filters with 
different coating thicknesses (Fig. 1). Furthermore, the signal intensities were highest with the 50 nm coating for 
each of the four most prominent peaks in the spectra (see Fig. 1 and Table 1). As such, all further experiments 
were performed using 0.45 μm pore size PVDF filters with a 50 nm gold coating applied through sputtered PVD.
Raman assessment of phantom urine infections. The mean spectra acquired in infected and control (uninfected) 
urine samples are displayed in Fig. 2a. Spectral differences were highlighted by centering and scaling the spectra 
of infected samples referenced on uninoculated negative controls (as depicted in Fig. 2b). Biochemical assign-
ment of peaks contributing to discrimination of infected from uninfected samples are presented in Table 2. PC-
LDA classification performance is presented in Table 3. Furthermore, following application of PC-LDA, infected 
and uninfected samples were identified with 91.1% accuracy [95% CI 83.2–96.0%; p value < 0.05], corresponding 
to a sensitivity and specificity of 97% and 80% respectively (Table 3).
Bacterial classification. The mean spectra of the three uropathogen species are presented in Fig. 3a. Discrimi-
nating peaks at 710, 855, 1004, 1235 and 1375  cm-1 are demonstrated in plots of bacterial species scaled and cen-
tered on each other in Fig. 3b. The PC-LDA classification performance for bacterial identification is presented in 
Table 1.  Rhodamine 6G peak intensities observed with different gold coating thicknesses for the four most 
prominent spectral peaks.
Raman 
Peak  (cm-1) Peak  Assignment32
Filter Gold Thickness (nm)
2.5 5 7.5 10 12.5 15 20 25 50 100 150
Peak intensity (a.u.)





700 1641 1292 1943 1993 1880 1818 1927 2829 1881 1789
1360 Xanthene Ring Stretching, C–H Bending 862 2183 2645 2595 2750 2534 2481 2590 3788 2579 2354
1511 Xanthene Ring Stretching, C–N Stretching 515 2364 2809 2793 2812 2619 2583 2684 3903 2585 2347
Figure 2.  (a) Mean normalized Raman spectra and standard deviations (shaded areas) for infected (red) and 
uninfected (blue) urine samples captured on SERS-active filters. (b) Mean spectrum with standard deviation 
(ribbon) of infected samples centered and scaled on uninfected controls demonstrating discriminatory peaks at 
710, 855, 1004, 1235, 1375 and 1505  cm-1.
Table 2.  Assignment of spectral peaks contributing to discrimination of infected samples from uninfected 
controls.
Raman peak  (cm−1) Assignment References
710 Phospholipids and lipids 33
855
Phenylalanine, proline and tyrosine 33,34
C–C stretching 33
1004
Phenylalanine and tyrosine 18,34
CH2 scissoring 34
1235 Amide III 18,33
1375 Lipid  CH3 deformation 33
1505 N = H bending 33
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Table 3.  Classification of infected and uninfected urine samples achieved using PC-LDA on the acquired 







Figure 3.  Identification of bacteria based on Raman spectra captured on SERS-active filters. (a) Mean Raman 
spectra with standard deviations (shaded areas) for Escherichia coli (red), Enterococcus faecalis (green) and 
Klebsiella pneumoniae (blue) captured on SERS-active filters. b) Spectra of individual species scaled and centered 
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Tables 4 and 5 and plotted graphically in Fig. 4. Amongst positive samples, the PC-LDA classification procedure 
provided clear discrimination of the three bacterial species (Fig. 4) and was able to identify the bacteria present 
in the samples with an accuracy of 91.6% (95% CI 81.6–97.2%; p value < 0.05; see Table 4). Furthermore, the 
sensitivity and specificity for identification of each bacterial species ranged from 86–100% (see Table 5).
Discussion. This work demonstrates that SERS-active filters can provide rapid and accurate uropathogen 
classification in human urine samples containing clinically relevant concentrations of bacteria  (105 CFU/ml). 
This suggests the potential to alter the current diagnostic paradigm for UTIs by allowing for precision antimi-
crobial therapy from the point of diagnosis. The 91.1% detection accuracy of infected samples provided by SERS-
active filters exceeds currently implemented UTI screening tests such as  urinalysis7,8,10,15. Superior accuracy to 
current screening tests has the potential to reduce delayed diagnosis, while also avoiding the development of 
AMR through overtreatment.
The uropathogen classification accuracy of 91.6% approaches current gold standard classification with M,C&S 
and comparable to that of UTI diagnostic technologies under development including multiplex polymerase chain 
reaction and mass  spectrometry35–37. Furthermore, sample processing was completed in minutes using widely 
available and low-cost equipment, indicating the potential for this approach to be developed into a point-of-care 
test in the future. Crucially, the ability to provide immediate bacterial classification would address a significant 
diagnostic need that is not addressed by existing technologies.
SERS has attracted much research attention as a result of its ability to provide accurate uropathogen clas-
sification without the need for prior amplification of the bacterial concentration through cell culture. SERS 
mediated uropathogen identification has been achieved with accuracies of up to 95.8% (e.g.18,21,34,38–44). However, 
circumventing bacterial amplification has required complex processes such as immunocapture, dielectrophore-
sis and use of optical tweezers to capture or aggregate pathogens, which are technically challenging or require 
expensive  equipment39,45.
In this work, a uropathogen classification accuracy of 91.6% was achieved, while physical processing was 
limited to vacuum filtration therein completing physical processing and Raman spectral capture in less than 
Table 4.  Bacterial classification in infected urine samples (achieved using PC-LDA). Accuracy 91.6% (95% CI: 
81.6–97.2%; p-value < 0.05), Cohen’s K = 0.88.
Predicted
Actual
Escherichia coli Enterococcus faecalis Klebsiella pneumoniae
Escherichia coli 20 0 0
Enterococcus faecalis 0 18 3
Klebsiella pneumoniae 0 2 17
Table 5.  Classification statistics for PC-LDA-based identification of bacterial species in infected samples.
Escherichia coli Enterococcus faecalis Klebsiella pneumoniae
Sensitivity 100% 90% 85%
Specificity 100% 93% 95%
Positive predictive value 100% 86% 90%
Negative predictive value 100% 95% 93%
Figure 4.  PC-LDA performed on Raman spectra from urine samples inoculated with Escherichia coli (red 
circle), Enterococcus faecalis (green triangle) and Klebsiella pneumoniae (blue square).
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15 min per sample. Vacuum filtration is a widely used microbiology technique to concentrate pathogens from 
large sample volumes using widely available and low-cost equipment, with processing completed  minutes46. 
Moreover, as vacuum filtration allows for rapid separation of uropathogens from urine, direct classification 
was achieved in urine samples rather than in suspensions or precultured samples. Additionally, a handheld 
Raman spectrometer was used in this study rather than the Raman microscopes commonly used in other SERS 
 work18,34,38–40,43. While Raman microscopes provide high-resolution spectra, the high costs, large footprints and 
requirements for technical expertise preclude their incorporation into point-of-care devices. This work comple-
ments a growing SERS literature base that aims to provide rapid uropathogen classification without the need for 
complex physical processing or expensive  microscopes19,22,42.
Many SERS mediated uropathogen classification studies have employed nanoparticle colloids to achieve 
surface  enhancement34,44. Ensuring nanoparticle consistency is technically challenging, requiring stringent 
experimental control, while avoiding particle aggregation necessitates controlled storage and prompt  use47,48. 
In this work, the SERS-active surface was applied through PVD—using a commercially available deposition 
system (Korvus Hex)—with close control of the metal thickness achieved using the deposition system’s control 
software. This fine control was used to assess multiple gold thicknesses, thereby allowing optimization of the 
surface enhancement effect. Lastly, in addition to the relative simplicity of the fabrication procedure, a further 
potential advantage of this approach is that the SERS-active filters are unlikely to require specialized storage or 
urgent use, and so may potentially be prepared in advance for use in point-of-care  testing49.
This work demonstrates proof of principal that SERS-active filters can capture pathogens directly from urine 
and provide Raman signal enhancement therein allowing for identification of infected samples and pathogen 
classification, however limitations are present. Pre-filtered urine from healthy volunteers was used in phantoms 
samples so as to avoid sample contamination. While this provided a simplified background solution without 
human sediment in this research, a similar background solution can be achieved in clinical samples through 
dual filtration to initially remove human sediment with a larger pore filter to capture sediment prior to pathogen 
capture on SERS-active filters. Additionally, in this research positive samples were constrained to three reference 
strain bacteria at a set concentration so as to minimize intra-class variation. Clinical samples contain a larger 
number of bacterial species of varying strain and concentration providing a greater classification challenge. As 
such, application to clinical samples may yield lower diagnostic accuracy, although this may potentially be miti-
gated by a larger training set. Similarly, clinical samples frequently have multiple pathogens which will provide 
a significantly more challenging classification. While this is likely to reduce the classification accuracy, it is less 
likely to affect the identification of positive samples which is arguably more valuable clinical information.
Conclusions. SERS-active filtration using gold coated membrane filters is a simple and rapid means of cap-
turing bacteria direct from urine while providing significant Raman signal enhancement for pathogen identifi-
cation. Applied to the diagnosis of UTIs in phantom urine samples, the technology provides accurate infection 
detection and bacterial classification with simple processing that can be completed in minutes. Thus, in the 
future, it may be possible to apply this approach to clinical samples to provide rapid, point-of-care bacterial 
identification, thereby permitting precision antimicrobial management.
Methods
Application of gold nanocoating. SERS-active membrane filters were created by applying a gold coat-
ing to commercially available membrane filters (0.45 μm pore size) using PVD. PVDF membrane filters were 
selected for this purpose as they have previously been demonstrated to have a simple baseline Raman spectrum 
with minimal variability, and therefore contribute minimal background  signal50. In order to establish the gold 
thickness for optimal Raman signal enhancement, different layer thicknesses were fabricated and assessed. Gold 
coatings were applied to the membrane filters (see Fig. 5b and Supplemental Fig. 1) using a Korvus Hex Deposi-
tion System using DC magnetron sputtering with a 2″ gold target onto a 4″ rotating stage. In addition to unsput-
tered controls, coating thicknesses of 2.5, 5, 7.5, 10, 12.5, 15, 20, 25, 50, 100 and 150 nm were applied. Coating 
thicknesses were controlled using quartz crystal monitoring.
SERS enhancement optimization and assessment. The Raman signal enhancement gained by differing gold 
coating thicknesses was assessed using Rhodamine 6G. A Rhodamine 6G solution was prepared and diluted in 
deionized water to a final concentration of 1 µM. 100 µl of Rhodamine 6G was then pipetted onto each mem-
brane filter. Raman spectra were collected from 10 separate filters for each coating thickness using an IDRaman 
mini 2.0 (Ocean Insight) with a point-and-shoot attachment. A custom, 3D-printed mount was used to position 
the spectrometer at the optimal focal distance (as described in previous  work50; also see Supplemental Fig. 2). 
For each filter, 5 spectra were collected (over the range 400–2300  cm−1) and averaged with 5 s acquisition times 
using a laser excitation power of 10 mW at 785 nm. The spectra were preprocessed by Savitsky-Golay filtering 
and background subtraction of a  7th order  polynomial51 (see Supplemental Fig. 3).
Diagnostic phantom UTIs. Phantom UTI samples. The diagnostic performance of the SERS-active 
membrane filters was assessed using phantom urine infection samples (Fig. 5a). Reference strain Escherichia 
coli ATCC25922, Enterococcus faecalis ATCC29212 and Klebsiella pneumoniae ATCC31883 were acquired from 
North West London Pathology Service and cultured on Columbia blood agar at 37º Celsius for 24 h. Harvested 
colonies were stored on a Microbank cryopreservation system at − 70º Celsius until required.
To create a phantom UTI sample a single Microbank bead was cultured in 3 ml brain–heart infusion at 37º 
Celsius for 24 h. The cultured bacteria were centrifuged at 11,000 rpm for 1 min. The resulting supernatant 
was discarded, and the bacterial pellet resuspended in phosphate buffered solution (PBS). This centrifuge and 
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resuspension process was repeated 5 times so as to remove remaining culture  medium52. The absorption at 
600 nm was used to dilute the resulting bacterial suspension down to a 0.5 McFarland Standard in PBS, cor-
responding to a bacterial load of 1.5 ×  108 CFU/ml. The resulting bacterial suspension was serially diluted to 
 105 CFU/ml in urine acquired from healthy human volunteers, which had been pre-filtered through a 0.2 μm 
pore size Corning vacuum filtration system to remove any human cellular material or contaminating microbes. 
This process culminated in cultured and washed uropathogens diluted to a clinically relevant concentration 
of  105 CFU/ml in human urine. A total of 90 samples were analyzed including 20 of each uropathogen and 30 
controls (uninoculated healthy urine). Urine was collected from healthy volunteers with their informed consent, 
and in accordance with Health Research Authority and Research Ethics Committee approval (IRAS: 237,195, 
REC: 18/LO/0314. Bromley Research Ethics committee). This work followed the principles of the World Medical 
Association’s Declaration of Helsinki. All microbiologic work was undertaken in a containment level 2 laboratory.
Sample processing and Raman capture. 30 ml Phantom urine samples underwent vacuum filtration through 
the SERS-active filters (50 nm gold coating, which provided the optimal signal enhancement. See Fig. 5c). An 
insert was designed and 3D-printed for vacuum filtration system which reduced the filter area from a diameter 
of 47 mm down to 10 mm (Supplemental Fig. 4). These inserts provided a number of benefits. Firstly, while the 
stage of the Korvus Hex will only allow for sputtering of four 47 mm filters per cycle, it can fit a single 90 mm 
filter which can subsequently be divided to provide over forty 10 mm filters. This is important as each coating 
cycle takes over an hour. Secondly, the uropathogens were concentrated into a smaller area, leading to a 22 times 
greater concentration. Finally, the insert allows for an additional upper layer housing a wider pore-size filter 
(Supplemental Fig. 4). This dual filtration will be integral in future work with clinical samples as large pore-size 
filters will remove patient cells and debris while allowing pathogens through to be captured on the SERS-active 
filters. Excess urine was washed off by subsequently vacuum filtering 10 ml PBS through the SERS-active filters. 
Thereafter, the SERS-active filters were removed from the vacuum filtration system and air dried prior to Raman 
capture. Physical processing was completed in under 10 min.
The processed SERS-active filters were transferred to a 3D-printed mounting system (described in previ-
ous  work50, and demonstrated in Supplemental Fig. 2), which acted to secure the samples at the focal point of 
the Raman spectrometer (Fig. 5d). Raman spectra were acquired (Fig. 1e) using an IDRaman mini 2.0 (Ocean 
Insight) handheld spectrometer (excitation wavelength—785 nm; laser power—50 mW). Raman spectra were 
collected across a range of 400–2300  cm-1 with a spectral resolution of 12–14  cm-1(technical specifications of the 
IDRaman mini 2.0 are available in Supplemental Table 1). For each filter (sample), 60 spectra were collected and 
Figure 5.  Methods overview. (a) Phantom urine samples were prepared by inoculating uropathogens 
(illustrated as blue ovals) into urine samples from healthy volunteers. (b) SERS-active filters were prepared by 
applying a 50 nm gold coating to polyvinylidene fluoride membrane filters using physical vapour deposition. 
(c) Vacuum filtration captured the uropathogens from urine and applied them directly to the SERS-enhancing 
surface (Red arrows indicate direction of vacuum). (d) Raman spectra were collected with a handheld 
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averaged with a 3 s acquisition time per spectrum (providing a total acquisition time of 3 min for each sample). 
The reference spectrum and raster orbital scanner functions of the spectrometer were used in all cases.
Spectral processing and analysis. The Raman spectra acquired from the filters were processed with 
R scripts (version 3.5.1) developed in-house (Fig. 5e). The spectra were first truncated from 500 to 2200  cm-1 
(as this range contained all visually discernible spectral peaks). High frequency noise and cosmic spikes were 
removed with a Savitzky-Golay filter before background subtraction using cubic spline interpolation. The back-
ground corrected spectra were then vector normalized by dividing each spectrum by its hypergeometric Euclid-
ean distance (d), the square root of the sum of the squared vector components (i.e. the intensity values at each 
wavelength, pi) (Eq. 1). Spectral preprocessing is demonstrated in Supplemental Fig. 3.
The mean Raman spectra were plotted for infected and control samples, as well as for individual bacterial 
species. Sample classification was performed using Principal Component—Linear Discriminant Analysis (PC-
LDA). Dimensionality reduction was achieved using principal component analysis and feature extraction, and the 
reduced features were then subjected to classification using linear discriminant analysis. To assess the diagnostic 
potential, the classification results were used to calculate the sensitivity, specificity and overall diagnostic accuracy 
for identification of the individual bacterial species and for identification of infected vs. uninfected samples. 
Finally, 95% confidence intervals (CIs), p values and Cohen’s K values were calculated to provide assessments of 
the statistical significance of the classification and the degree of agreement with the ground truth (i.e. the actual 
infection statuses or the actual bacterial species).
Data availability
The data and code are made available to the editorial board and referees, including SERS coating Thickness 
dataset, the phantoms urine dataset and the R script.
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